Chie Kudo-Saito

5PUBLICATIONS
14CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 14, 2026
IL10RB expression in cancer cells is associated with evolutionary changes to solidify treatment resistance.

Chie Kudo-Saito, Hiroki Ozawa, Hiroshi Imazeki

|Feb 02, 2026
ANGPTL3 in the Peripheral Circulation Is Associated with Resistance to Anti-PD1 Therapy in Advanced Gastric Cancer.

Chie Kudo-Saito, Hirokazu Shoji, Kengo Nagashima

|Oct 17, 2025
IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.

Chie Kudo-Saito, Hiroshi Imazeki, Kengo Nagashima

|Nov 03, 2024
Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study).

Hirokazu Shoji, Chie Kudo-Saito, Kengo Nagashima

|Jul 15, 2021
CD11b+CTLA4+ myeloid cells are a key driver of tumor evasion in colorectal cancer.

Hiroshi Imazeki, Yamato Ogiwara, Mami Kawamura

Pageof 1